Resultados da busca - Ina Müller

  • Mostrando 1 - 5 resultados de 5
Refinar Resultados
  1. 1
    A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes

    A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes por Niels Schaft, Jan Dörrie, Ina Müller, Verena Beck, Stefanie Baumann, Tanja Schunder, Eckhart Kämpgen, Gerold Schuler

    Publicado em 2005
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  2. 2
    Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation

    Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation por Niels Schaft, Jan Dörrie, Peter Thumann, Verena Beck, Ina Müller, Erwin Schultz, Eckhart Kämpgen, Detlef Dieckmann, Gerold Schuler

    Publicado em 2005
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies

    Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies por Ilka Knippertz, Marcello F. Stein, Jan Dörrie, Niels Schaft, Ina Müller, Andrea Deinzer, Alexander Steinkasserer, Dirk M. Nettelbeck

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHO show higher ADCC levels and improved event-free survival

    Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHO show higher ADCC levels and... por Nikolai Siebert, Christian Fuglesang S. Jensen, Sascha Troschke‐Meurer, Maxi Zumpe, Madlen Jüttner, Karoline Ehlert, Silke Kietz, Ina Müller, Holger N. Lode

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)

    Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (A... por Jens Atzpodien, K. Neuber, Darab Kamanabrou, Michael Fluck, E B Bröcker, C. Neumann, Thomas M. Rünger, Gerold Schuler, Peter Von Den Driesch, Ina Müller, E. Paul, T Patzelt, Martina Reitz

    Publicado em 2002
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: